Potency and pharmacokinetics of gestagens
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 41 (5) , 533-550
- https://doi.org/10.1016/0010-7824(90)90062-z
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Interactions of Contraceptive Steroids with Binding Proteins and the Clinical ImplicationsAnnals of the New York Academy of Sciences, 1988
- New Drugs: Practical clinical pharmacology: monitoring drug concentrations and clinical trialsBMJ, 1988
- Comparative pharmacokinetics of levonqrgestrel and ethinyloestradiol following intravenous, oral and vaginal administrationContraception, 1987
- Variability of pharmacokinetic parameters for contraceptive steroidsJournal of Steroid Biochemistry, 1983
- Distribution and percentages of non-protein bound contraceptive steroids in human serumThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- On the use of Plasma Proteins as Indicators of the Metabolic Effects of Combined Oral ContraceptivesPublished by Wiley ,1982
- The pharmacokinetics of levonorgestrel and ethynylestradiol in women — Studies with ovran and ovranetteContraception, 1981
- Circulating levels of synthetic steroids in women using a ‘triphasic’ formulation: a comparison with different ethinyloestradiol dosesJournal of Obstetrics and Gynaecology, 1981
- EFFECT OF VARYING AMOUNTS OF ETHINYL OESTRADIOL IN THE COMBINED ORAL CONTRACEPTIVE ON PLASMA SEX HORMONE BINDING GLOBULIN CAPACITY IN NORMAL WOMENBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979